# CMV Modulation of the Immune System in ANCA-associated Vasculitis

> **NCT01633476** · PHASE2 · UNKNOWN · sponsor: **Professor Lorraine Harper** · enrollment: 38 (actual)

## Conditions studied

- ANCA Associated Vasculitis
- CMV Infection

## Interventions

- **DRUG:** Valaciclovir

## Key facts

- **NCT ID:** NCT01633476
- **Lead sponsor:** Professor Lorraine Harper
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-07
- **Primary completion:** 2016-02
- **Final completion:** 2017-09
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2016-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01633476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01633476, "CMV Modulation of the Immune System in ANCA-associated Vasculitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01633476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*